Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

33.78
+1.926.03%
Post-market: 33.73-0.0550-0.16%19:59 EDT
Volume:14.71M
Turnover:492.64M
Market Cap:7.88B
PE:-54.22
High:34.46
Open:31.67
Low:31.60
Close:31.86
52wk High:65.30
52wk Low:13.74
Shares:233.31M
Float Shares:212.45M
Volume Ratio:1.11
T/O Rate:6.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6230
EPS(LYR):0.5123
ROE:-32.03%
ROA:-2.21%
PB:24.32
PE(LYR):65.94

Loading ...

U.S. Stocks on the Move-booz Allen Hamilton, Sensient, Amkor

Reuters
·
Jul 24

Movement Alert|Hims & Hers Health Inc. Rises 5.04% in Regular Trading, FDA Advisory Committee Backs Bpc-157 Peptide for Pharmacy Compounding

Market Focus
·
Jul 24

Truist Raises Price Target on Hims & Hers Health to $27 From $23, Keeps Hold Rating

MT Newswires Live
·
Jul 24

Hims & Hers Health Inc : Truist Securities Raises Target Price to $27 from $23

THOMSON REUTERS
·
Jul 24

Moderately bullish activity in Hims and Hers Health with shares up 3.39%

TIPRANKS
·
Jul 24

Hims & Hers Health is Maintained at Neutral by Citigroup

Dow Jones
·
Jul 24

FDA Advisers Back First Four of Seven Unapproved Peptides Under Review for Looser Rules

Reuters
·
Jul 24

Why Is Hims & Hers Health Stock Surging on Thursday?

Benzinga
·
Jul 24

Hims Gains After FDA Panel Votes to Place Popularly Used Peptide Bpc-157 on Compounding List

Reuters
·
Jul 24

Hims & Hers Health Shares up 10% After FDA Advisory Panel Votes to Place Bpc-157 Peptide on Allowed Pharmacy Compounding List

THOMSON REUTERS
·
Jul 24

Movement Alert|Hims & Hers Health Inc. Rises 6.69% in Regular Trading, FDA Peptide Drug Access Advocacy Gains Market Approval

Market Focus
·
Jul 24

Hims & Hers Shares up 2% After Telehealth Firm Urged FDA to Broaden Access to Some Peptides in Panel Meeting

THOMSON REUTERS
·
Jul 23

Peptides Could Soon Become Widely Available in the U.S. Here's What Happens Next.

Dow Jones
·
Jul 23

Hims & Hers Health Inc : Citigroup Raises Target Price to $35 from $28

THOMSON REUTERS
·
Jul 23

Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares Valued at $229,075.99

Reuters
·
Jul 21

Trump's FDA May Soon Back Peptides. Should You Buy In?

Dow Jones
·
Jul 18

Hims & Hers Accounting Chief Exits

Dow Jones
·
Jul 18

Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company

THOMSON REUTERS
·
Jul 18

Movement Alert|Hims & Hers Health Falls 5.05% in Regular Trading, Trading at $32.87

Market Focus
·
Jul 17

Cboe data shows mixed options sentiment in Hims and Hers Health with shares down 9.35%

TIPRANKS
·
Jul 17